Original Research

Leuprolide acetate 1-, 3- and 6-monthly depot formulations in androgen deprivation therapy for prostate cancer in nine European countries: evidence review and economic evaluation

Wex J, Sidhu M, Odeyemi I, Abou-Setta AM, Retsa P, Tombal B

ClinicoEconomics and Outcomes Research 2013, 5:257-269

Published Date: 24 June 2013